5178
F. Michalek et al. / Journal of Organometallic Chemistry 691 (2006) 5172–5180
+
4
.3.6. (10b) (41 lmol/g Ru)
[M ], 236 (7), 184 (85), 155 (40), 96 (87), 91 (37), 69
IR (neat): 3500, 3312, 3059, 2873, 2128, 1943, 1711,
643, 1539, 1489, 1455, 1400, 1350, 1297, 1255, 1119,
(35), 67 (30), 41 (24).
1
1
ꢁ
1
042, 997, 950, 851, 769, 731, 698, 580 cm
.
4.5.3. 3-Methyl-1-[(4-methylphenyl)sulfonyl]-2,5-dihydro-
1H- pyrrole (13c) [23]
1
4
1
4
1
4
.3.7. (11a) (16 lmol/g Ru)
IR (neat): 3606, 3431, 2982, 2935, 2857, 1979, 1872,
652, 1622, 1385, 1076, 916, 803, 673 cm
H NMR (400 MHz, CDCl ): d = 1.66 (m , 3H,
3
c
CH@C(CH )CH ), 2.43 (s, 3H, SO PhCH ), 3.95–3.98
3
2
2
3
ꢁ
1
.
(m, 2H), 4.05–4.09 (m, 2H), 5.25 (m , 1H, CH CH@
c
2
C(CH )CH ), 7.32 (m, 2H, arom.), 7.72 (m, 2H, arom.);
3
2
1
3
.3.8. (11b) (5 lmol/g Ru)
IR (neat): 3601, 3425, 2983, 2936, 1977, 1869, 1740,
653, 1623, 1384, 1080, 916, 804, 673 cm
C NMR (100.6 MHz, CDCl ): d = 14.1, 21.5, 55.1,
3
57.7, 119.1, 127.5, 129.7, 134.4, 135.1, 143.3; GC/MS–EI
ꢁ
1
+
.
(70 eV); m/z (%) = 237 (22) [M ], 236 (16), 222 (23)
+
+
[
[C
C H NO S ], 172 (5), 155 (92) [C H O S ], 91 (67)
1
1
12
þ
2
7
7
2
+
.4. General procedure: Recycling experiments with 12a
7
H ], 82 (100) [C H N ], 80 (10), 67 (7), 65 (17), 55 (10).
7
5
8
The supported catalysts 8–11 were placed in a reaction
4.5.4. 5-Methyl-1-[(4-methylphenyl)sulfonyl]-1,2,3,6-
tetrahydropyridine (13d) [23]
tube under air and 12a was added from a stock solution
1 mL, 50 lmol, 0.05 M in CH Cl ). The reaction mixture
1
(
H NMR (400 MHz, CDCl ): d = 1.64–1.66 (m, 3H,
2
2
3
was shaken for 2 h at 60 ꢁC (oil bath). Then, a sample of
the reaction mixture was taken to determine the conversion
by HPLC. After this, the supernatant solution was removed
and the solid phases were washed with CH Cl (3 · 1.5 mL).
Then, fresh substrate wasadded and the next run wasstarted.
In total, five consecutive runs were performed like this.
CH C(CH )@CHR), 2.08–2.13 (m, 2H, NCH CH ), 2.42
2
3
2
2
(s, 3H, SO PhCH ), 3.16 (t, J = 5.8 Hz, 2H, NCH CH ),
2
3
2
2
3.52 (ddq, J = 5.5, 2.3, 2.3 Hz, 2H, NCH CH@C(CH )-
2
3
CH ), 5.30 (ddq, J = 6.5, 3.2, 1.6 Hz, 1H, CH CH@
2
2
2
2
C(CH )CH ), 7.31 (m
0
0
, Japp = 8.2 Hz, 2H, arom.),
3
2
AA BB
1
3
7.67 (m
0
0
, Japp = 8.2 Hz, 2H, arom.);
C NMR
AA BB
(
100.6 MHz, CDCl ): d = 21.5, 22.9, 30.0, 42.9, 44.8,
3
4
.5. General procedure: RCM reactions
116.6, 127.7, 129.6, 132.8, 133.4, 143.4; GC/MS–EI
+
(
70 eV); m/z (%) = 252 (14), 251 (100) [M ], 237 (14), 236
+
+
The supported catalysts 8–11 were placed in a reaction
(92) [C H NO S ], 155 (61) [C H O S ], 147 (6), 96
12 14 2 7 7 2
(70) [C H N ], 94 (29), 91 (47) [C H ], 69 (55), 68 (15),
6 10
7
+
þ
7
tube under air and the a,x-olefin was added from a stock
solution (1 mL, 50 lmol, 0.05 M in CH Cl ). The reaction
67 (12), 65 (14), 53 (6), 41 (25).
2
2
mixture was shaken for 2 h at 60 ꢁC (oil bath). After cool-
ing to r.t., the supernatant solution was removed and the
solid phases were washed with CH Cl (3 · 1.5 mL). Then,
4.5.5. Cyclopent-3-ene-1,1-dicarboxylic acid diethyl ester
(13e) [47]
2
2
1
fresh substrate was added and the next run was started.
H NMR (400 MHz, CDCl ): d = 1.25 (t, J = 7.1, 6 H,
3
1
The conversions were determined by H-NMR.
ACH CH ), 3.01 (s, 4H, ACH ACH@CHACH A), 4.20
2
3
2
2
(
q, J = 7.1, 4H, ACH CH ), 5.61 (s, 2H, ACH ACH@
2
3
2
13
4
[
.5.1. 1-(Toluene-4-sulfonyl)-2,5-dihydro-1H-pyrrole (13a)
45]
CHACH A); C NMR (100.6 MHz, CDCl ): d = 14.0,
2
3
40.9, 58.9, 61.2, 127.8, 172.3; MS–EI (70 eV): m/z
(%) = 212 (63) [M ], 166 (60), 138 (100), 111 (38), 93
1
+
H NMR (400 MHz, CDCl ): d = 2.42 (s, 3H, Ar-CH ),
3
3
4
.12 (s, 4H, CH CH@CHCH ), 5.65 (s, 2H, CH CH@
(32), 79 (40), 66 (54).
2
2
2
CHCH ), 7.32 (m
0
0
, Japp = 8.1 Hz, 2H, arom.), 7.72
2
AA BB
1
3
(
m
0
0
,
Japp = 8.1 Hz, 2H, arom.);
C
NMR
4.5.6. (Cyclopent-2-enyloxymethyl)-benzene (13f) [48]
1
AA BB
(
100.6 MHz, CDCl ): d = 21.6, 54.9, 125.5, 127.5, 129.8,
H NMR (500 MHz, CDCl ): d = 1.82–1.89 (m, 1H,
3
3
+
0 0 0 0
H -4 /H -4 ), 2.12–2.19 (m, 1H, H -4 /H -4 ), 2.23–2.30
A B A B
1
1
34.4, 143.5; MS–EI (70 eV): m/z (%) = 223 (50) [M ],
0 0 0 0
(m, 1H, H -5 /H -5 ), 2.47–2.55 (m, 1H, H -5 /H -5 ),
A B A B
55 (52), 91 (92), 86 (13), 84 (20), 68 (100), 65 (24), 41 (24).
4.51 (d, JAB = 11.7 Hz, 1H, HCHAAr), 4.55 (d,
4.5.2. 1-(Toluene-4-sulfonyl)-2,3,4,7-tetrahydro-1H-
azepine(13b) [46]
JAB = 11.7 Hz, 1H, HCHAAr), 4.67 (m , 1H, CHOR),
c
0
0
5.88–5.91 (m, 1H, H-3 ), 6.01–6.04 (m, 1H, H-2 ), 7.24–
1
13
H NMR (300 MHz, CDCl ): d = 1.80 (m , 2H), 2.18
7.37 (m, 5H, arom.); C NMR (100.6 MHz, CDCl3):
3
c
(
m , 2H), 2.41 (s, 3H, CH AAr), 3.39 (t, J = 6.1 Hz,
d = 29.8, 31.1, 70.6, 84.5, 127.4, 127.8, 128.3, 130.8,
c
3
2
H, NACH ACH A), 3.83 (d, J = 4.5 Hz,
2
H,
135.7, 138.9; MS–CI (NH , 130 eV): m/z (%) = 192 (12)
2
2
3
+
+
NCH CH@CHA), 5.64 (dt, J = 5.1, 10.6 Hz, 1H, H-2/
[(M + NH ) ], 175 (4) [(M + H) ], 157 (10), 126 (21), 108
2
4
H-3), 5.77 (dt, J = Hz, 5.3, 10.9 Hz, 1H, H-2/H-3), 7.28
(17), 91 (36), 84 (100), 67 (7).
(
8
m
0
0
, Japp = 8.2 Hz, 2H, arom.), 7.68 (m
0
0
, Japp =
AA BB
AA BB
1
3
.1 Hz, 2H, arom.); C NMR (100.6 MHz, CDCl3):
d = 21.5, 26.9, 31.0, 46.4, 49.7, 126.7, 127.3, 129.6,
33.0, 136.5, 143.1; MS–EI (70 eV): m/z (%) = 251 (100)
4.5.7. (Cyclohex-2-enyloxymethyl)-benzene (13g) [49]
1
H NMR (500 MHz, CDCl ): d = 1.51–1.59 (m, 1H),
3
1
1.71–1.89 (m, 3H), 1.91–1.99 (m, 1H), 2.02–2.10 (m, 1H),